SOD1 and amyotrophic lateral sclerosis: Sproviero et al. reported that comparing levels of SOD1 and ALS-associated biomolecules in plasma EVs between patients with ALS and healthy controls has provided evidence supporting further exploration of ALS-related SOD1 levels in various EV types and suggesting its potential as a biomarker for ALS [112].